REG - Surgical Innovations - Issue of Shares <Origin Href="QuoteRef">SUNU.L</Origin>

Surgical InnovationsAnnouncement

27/04/2016 08:00

RNS Number : 4697W
Surgical Innovations Group PLC
27 April 2016
Surgical Innovations Group plc
(the "Company")
Issue of Shares
The Company has issued and allotted a total of 811,644 ordinary shares of 1p each ("Shares") at a price of 1.825 pence per share to Nigel Rogers, Executive Chairman, and Michael Mc Mahon, Alistair Taylor and Paul Hardy, Non-Executive Directors. 
159,559 Shares have been issued and allotted to Nigel Rogers in lieu of remuneration in accordance with the terms of his engagement with the Company as referred to in the announcement of his appointment on 28 October 2015. Following this transaction, his beneficial holding is 1,765,273 Shares, representing approximately 0.36% of the enlarged issued ordinary share capital.
164,384 Shares have been issued and allotted to Michael McMahon in lieu of remuneration in accordance with the terms of his engagement with the Company. Following this transaction, his beneficial holding is 17,782,895 Shares, representing approximately 3.65% of the enlarged issued ordinary share capital.
273,973 Shares have been issued and allotted to Paul Hardy in lieu of remuneration in accordance with the terms of his engagement with the Company as referred to in the announcement of his appointment on 21 January 2016. Due to an erroneous communication from his broker, the previous notification of his holding stated that on 21 March 2016 Paul Hardy had purchased 750,000 shares at 1.65 pence per share. This should have read 850,000 shares at 1.6559 pence. Mr. Hardy's beneficial holding (comprising the holdings of Hardy Transaction Management Limited, a company in which he has a controlling interest, and his SIPP) is now 1,773,973 Shares, representing approximately 0.36% of the enlarged issued ordinary share capital.
213,728 Shares have been issued and allotted to Alistair Taylor in lieu of remuneration in accordance with the terms of his engagement with the Company as referred to in the announcement of his appointment on 21 January 2016. Following this transaction, his beneficial holding is 213,728 Shares, representing approximately 0.04% of the enlarged issued ordinary share capital.
As the Shares have been issued in lieu of remuneration for the first quarter of 2016, the issue price was set at the closing price on the date of the Company's payroll in March.
Application will be made for 811,644 Shares to be admitted to trading on AIM ("Admission") which is expected to take place on 3 May 2016. 
Following Admission, the total number of ordinary shares in issue will be 487,087,354 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the purposes of the Disclosure and Transparency Rules.
ENDS
For further information please visit www.sigroupplc.com or contact:
Enquiries:
For further information please contact:
Surgical Innovations Group Plc
www.sigroupplc.com
Nigel Rogers, Executive Chairman
Tel: 0113 230 7597
Melanie Ross, Group FD & Managing Director, SI Ltd
WH Ireland Limited (NOMAD & Broker)
Tel: 0113 394 6600
Tim Feather/Liam Gribben
Walbrook PR (Financial PR & Investor Relations)
Tel: 020 7933 8780
or si@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Natalie Bruce
Mob: 07884 666 994

This information is provided by RNS
The company news service from the London Stock Exchange
  END
IOEQDLBLQZFEBBE